Business
Up 300% in 1 year, what’s driving the Incannex Healthcare (ASX:IHL) share price?
The Incannex Healthcare Ltd (ASX: IHL) share price, which has shot up 310% in the past 12 months, has remained relatively flat in today’s trade.
We take a look at the ASX healthcare share’s latest announcement on its accelerated drug study, along with its share price performance over the past year.
What did Incannex Healthcare report?
Incannex Healthcare shares are flat today after the company reported it has partnered with Monash Trauma Group to study the effectiveness of its proprietary drug on treating concussions.
The in vivo study, to be conducted on rats, will assess the “neuroprotective capability of…
-
General18 hours agoByford rail extension opening marks final stage of Perth Metronet
-
Noosa News23 hours agoFatal traffic crash, Baringa – Sunshine Coast
-
General19 hours agoMango the muster cat draws attention to western Queensland’s ongoing recovery
-
Business21 hours agoWhat $10,000 invested in the iShares S&P 500 IVV ETF could be in 10 years